These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33650759)

  • 1. Gynaecological cancers and their cell lines.
    Skok K; Gradišnik L; Maver U; Kozar N; Sobočan M; Takač I; Arko D; Kavalar R
    J Cell Mol Med; 2021 Apr; 25(8):3680-3698. PubMed ID: 33650759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial cancer and its cell lines.
    Skok K; Maver U; Gradišnik L; Kozar N; Takač I; Arko D
    Mol Biol Rep; 2020 Feb; 47(2):1399-1411. PubMed ID: 31848918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic immunohistochemistry in gynaecological neoplasia: a brief survey of the most common scenarios.
    Kuhn E; Ayhan A
    J Clin Pathol; 2018 Feb; 71(2):98-109. PubMed ID: 29183921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications.
    El-Ghobashy AE; Saidi SA
    Eur J Surg Oncol; 2009 Jul; 35(7):675-85. PubMed ID: 18980825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membrane.
    Sieuwerts AM; Klijn JG; Foekens JA
    Clin Exp Metastasis; 1997 Jan; 15(1):53-62. PubMed ID: 9009106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primitive malignant tumour in patients with gynaecological cancer.
    Nunes F; Saraiva J; Francisca A; Botica MJ; Diniz Mdo C; Cabral I
    Eur J Gynaecol Oncol; 1997; 18(6):488-91. PubMed ID: 9443017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.
    Singh N; Gilks CB
    Histopathology; 2017 Jan; 70(1):56-69. PubMed ID: 27960241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of second and third malignant tumors in patients with gynaecological cancer].
    Ivanov S; Garanina Z
    Akush Ginekol (Sofiia); 2005; 44(3):22-4. PubMed ID: 16028387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current classification of malignant tumours in gynecological oncology--part II].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Oct; 76(5):360-6. PubMed ID: 22132636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth response to tumour necrosis factor alpha of human gynaecological cancer cell lines.
    Beesley JS; Kirby PL; Takeda S; Stackpoole A; Soutter WP; White JO
    Cytokine; 1998 Jun; 10(6):432-40. PubMed ID: 9632529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The culture conditions and outputs from breast cancer cell line in vitro experiments.
    Ravi M; Sneka MK; Joshipura A
    Exp Cell Res; 2019 Oct; 383(2):111548. PubMed ID: 31398351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current classification of malignant tumours in gynecological oncology--part I].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Sep; 76(4):279-84. PubMed ID: 22026069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation.
    Garg K; Karnezis AN; Rabban JT
    Pathology; 2018 Feb; 50(2):238-256. PubMed ID: 29373116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple cancers in gynecologic oncology].
    Schröcksnadel H; Fuith LC; Hetzel H
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):710-4. PubMed ID: 3234703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of gynaecological cancer treatment on physical activity levels: a systematic review of observational studies.
    Lin KY; Edbrooke L; Granger CL; Denehy L; Frawley HC
    Braz J Phys Ther; 2019; 23(2):79-92. PubMed ID: 30473435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does debulking of enlarged positive lymph nodes improve survival in different gynaecological cancers?
    Somashekhar SP
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):870-83. PubMed ID: 26043964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gynaecological cancer and night shift work: A systematic review.
    Schwarz C; Pedraza-Flechas AM; Lope V; Pastor-Barriuso R; Pollan M; Perez-Gomez B
    Maturitas; 2018 Apr; 110():21-28. PubMed ID: 29563031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tissue culture device for culturing breast tumours and gynaecological tissues.
    Bishun N; Mills J; Williams DC
    Cytologia (Tokyo); 1975 Mar; 40(1):91-6. PubMed ID: 1157521
    [No Abstract]   [Full Text] [Related]  

  • 19. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review.
    Chittenden BG; Fullerton G; Maheshwari A; Bhattacharya S
    Reprod Biomed Online; 2009 Sep; 19(3):398-405. PubMed ID: 19778486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibilities and limitation of endoscopic procedures in oncological gynaecology.
    Stelmachów J; Spiewankiewicz B
    Eur J Gynaecol Oncol; 2005; 26(1):21-3. PubMed ID: 15754994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.